AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Lineage Cell Therapeutics Inc. Director's Dealing 2016

Nov 17, 2016

6895_dirs_2016-11-16_5752095e-735c-40cb-82c0-81680e569b02.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BIOTIME INC (BTX)
CIK: 0000876343
Period of Report: 2016-10-19

Reporting Person: KNIGHT JAMES A. (Sr VP, Head of Corporate Dev)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares, no par value	17036	Direct